Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
MayaMD is a Clinical AI Platform built for healthcare scenarios. The official site positions it as a “neuro-symbolic AI” medical platform: it combines proprietary knowledge-engineering systems with the natural conversational capabilities of generative AI for clinical AI Agents, virtual triage, remote patient management, and patient communication. It emphasizes evidence-based practice, clinical validation, human support in the loop, and covers different stages of the patient journey, from triage and discharge education to chronic and acute disease management.
Based on the site content, MayaMD is not a general-purpose chatbot, but a conversational AI and decision-support system designed for clinical interventions. It supports real-time data, alerts, and predictive analytics, with the goal of helping care teams improve outcomes and reduce information silos. Example use cases include discharge education for heart-failure patients, AI symptom checking, and virtual triage. The official site reports outcomes such as over $40,000 in additional monthly revenue for a small clinic, a 40% reduction in intake time for a health clinic, a 31% reduction in readmissions for a healthcare system, and 94%+ triage accuracy. These figures are attractive, but the site does not provide details on sample size, study design, or third-party validation, so they should be evaluated with caution.
The official site does not disclose pricing, plans, free trials, or payment methods, nor does it clarify whether the product is offered as SaaS, private deployment, or a custom institutional contract. On APIs and integrations, it only mentions connecting patients with care teams and eliminating silos, without specifying support for EHR/EMR, FHIR, HL7, or particular third-party systems. For healthcare organizations, key questions before procurement should include deployment timeline, interface capabilities, data migration, access control, and the boundaries of clinical responsibility.
Its strengths are a clear positioning and a focus on safety, evidence-based practice, and clinical validation in high-risk healthcare scenarios. The product covers real-world workflows such as triage, follow-up, RPM, and discharge education, and it is backed by case studies and innovation awards. The drawbacks are limited disclosure of key information: there is no clear explanation of pricing, Chinese-language support, privacy compliance, data security, model limitations, or integration standards, and some performance claims lack verifiable context.
MayaMD is better suited to clinics, hospital systems, rural healthcare networks, and care teams that need to improve patient outreach, triage efficiency, and readmission management. Access from China cannot be determined from the official site content and is therefore listed as unknown for now; payment methods are also not disclosed. If deployed in China, key considerations would include medical data compliance, local EHR integration, Chinese medical semantic capability, and regulatory approval. Comparable tools include Infermedica, Ada Health, Buoy Health, Healthily, and other virtual triage or digital health products.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on mayamd.ai official site.
mayamd.ai is an United States AI Apps provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach mayamd.ai directly.